Schonfeld Strategic Advisors LLC Takes Position in Doximity, Inc. (NASDAQ:DOCS)

Schonfeld Strategic Advisors LLC acquired a new stake in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 13,600 shares of the company's stock, valued at approximately $726,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the stock. Barclays PLC raised its position in shares of Doximity by 60.5% during the third quarter. Barclays PLC now owns 53,401 shares of the company's stock worth $2,327,000 after purchasing an additional 20,125 shares during the period. Franklin Resources Inc. lifted its position in Doximity by 564.1% in the 3rd quarter. Franklin Resources Inc. now owns 83,098 shares of the company's stock worth $3,487,000 after buying an additional 70,585 shares in the last quarter. GAMMA Investing LLC boosted its stake in shares of Doximity by 20.6% during the 4th quarter. GAMMA Investing LLC now owns 1,735 shares of the company's stock valued at $93,000 after buying an additional 296 shares during the period. Nordea Investment Management AB increased its stake in shares of Doximity by 6.2% in the fourth quarter. Nordea Investment Management AB now owns 52,176 shares of the company's stock worth $2,815,000 after acquiring an additional 3,053 shares during the last quarter. Finally, Wedmont Private Capital acquired a new stake in Doximity during the fourth quarter valued at $298,000. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Doximity Stock Performance

Shares of NASDAQ:DOCS traded down $0.66 on Tuesday, reaching $60.38. The company's stock had a trading volume of 3,476,085 shares, compared to its average volume of 2,029,798. The company has a 50-day simple moving average of $57.82 and a 200 day simple moving average of $57.50. The company has a market cap of $11.27 billion, a P/E ratio of 60.38, a PEG ratio of 4.10 and a beta of 1.41. Doximity, Inc. has a 52-week low of $23.27 and a 52-week high of $85.21.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the company. Truist Financial cut their price objective on Doximity from $65.00 to $58.00 and set a "hold" rating on the stock in a research note on Thursday, April 10th. Needham & Company LLC upped their target price on shares of Doximity from $65.00 to $82.00 and gave the stock a "buy" rating in a report on Friday, February 7th. Wells Fargo & Company reissued an "equal weight" rating on shares of Doximity in a report on Friday, February 7th. Morgan Stanley reduced their price target on shares of Doximity from $71.00 to $60.00 and set an "equal weight" rating on the stock in a research report on Thursday, April 24th. Finally, Raymond James reissued an "outperform" rating and set a $83.00 price target (up from $65.00) on shares of Doximity in a research note on Friday, February 7th. Eleven analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, Doximity presently has a consensus rating of "Moderate Buy" and a consensus price target of $65.39.

Insiders Place Their Bets

In related news, Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $56.93, for a total transaction of $113,860.00. Following the sale, the director now owns 16,618 shares in the company, valued at approximately $946,062.74. This represents a 10.74% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CFO Anna Bryson sold 45,000 shares of Doximity stock in a transaction on Thursday, May 1st. The stock was sold at an average price of $57.23, for a total transaction of $2,575,350.00. Following the transaction, the chief financial officer now directly owns 357,165 shares of the company's stock, valued at $20,440,552.95. The trade was a 11.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. 37.40% of the stock is currently owned by insiders.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.